Oral Yeast Carriage and Salivary Antifungal Activity
Project Number1R03DE016699-01A2
Contact PI/Project LeaderHELMERHORST, EVA JOSEPHINE
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
DESCRIPTION (provided by applicant): It is well known that the maintenance of oral hard and soft tissues is dependent on the presence of saliva since conditions negatively affecting salivary flow lead to rapid deterioration of oral health. This recognition of the importance of saliva has led to the structural and functional characterization of the major salivary proteins. Some of these proteins were found to exhibit strong antifungal activity in in vitro assays. While the total salivary antifungal activity is expected to be represented by the activities of all individual antifungal components, in vitro assays with total saliva show surprisingly little or no fungicidal activity. We have shown that saliva can be rendered active by lowering or removing its electrolytes making it possible to evaluate antifungal activities in the presence of all salivary proteins. It is well known that healthy individuals differ with respect to the carrier status of the oral opportunistic pathogen Candida albicans. Notably, every subject affected with oral candidiasis must have acquired carrier status before developing the disease. The focus of this application is based on the hypothesis that differences in salivary antifungal capacity between healthy individuals may explain differences in Candida carriage levels. To investigate this, it is planned to 1) assess the full extent of fungistatic and fungicidal activities of salivary secretions under native and desalted conditions, 2) investigate whether there is a relationship between whole saliva ionic strength or salivary antifungal capacity and oral yeast carriage, 3) initiate studies on the identification of components responsible for the activity of dialyzed parotid secretion. This project is the first step toward a more comprehensive investigation of the factors which promote host protection in a salivary environment. The experiments outlined here will provide the basis for a better understanding of antifungal mechanisms exerted by saliva in the oral cavity.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
05-February-2007
Project End Date
31-January-2009
Budget Start Date
05-February-2007
Budget End Date
31-January-2008
Project Funding Information for 2007
Total Funding
$81,250
Direct Costs
$50,000
Indirect Costs
$31,250
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Dental and Craniofacial Research
$81,250
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R03DE016699-01A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03DE016699-01A2
Patents
No Patents information available for 1R03DE016699-01A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03DE016699-01A2
Clinical Studies
No Clinical Studies information available for 1R03DE016699-01A2
News and More
Related News Releases
No news release information available for 1R03DE016699-01A2
History
No Historical information available for 1R03DE016699-01A2
Similar Projects
No Similar Projects information available for 1R03DE016699-01A2